Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Parr

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Respiratory Research|February 15, 2008
Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advancesDavid G Parr, Martin Sevenoaks, Chunqin Deng, et al.
Respiratory Research|August 15, 2009
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiencyDavid G Parr, Asger Dirksen, Eeva Piitulainen, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2004
Influence of calibration on densitometric studies of emphysema progression using computed tomographyDavid G Parr, Berend C Stoel, Jan Stolk, et al.
COPD|April 20, 2010
Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiencyJayne Holme, Paul A Dawkins, Ellen K Stockley, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2007
Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiencyDavid G Parr, Peter G Guest, John H Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|July 28, 2012
Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomographyDeepak R Subramanian, Lee Jenkins, Ross Edgar, et al.
Respiratory Research|October 6, 2010
Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometryRobert A Stockley, David G Parr, Eeva Piitulainen, et al.
Respiratory Research|November 23, 2006
Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive studyDavid G Parr, Andrew J White, Darren L Bayley, et al.
European Journal of Internal Medicine|April 30, 2003
Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparinAlbert Y.H. Lim, David G. Parr, David E. Stableforth, et al.
Archivos De Bronconeumologia|July 25, 2022
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research CollaborationDavid G Parr, Joanna Chorostowska-Wynimko, Angelo Corsico, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Respiratory Research|February 15, 2008
Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advancesDavid G Parr, Martin Sevenoaks, Chunqin Deng, et al.
Respiratory Research|August 15, 2009
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiencyDavid G Parr, Asger Dirksen, Eeva Piitulainen, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2004
Influence of calibration on densitometric studies of emphysema progression using computed tomographyDavid G Parr, Berend C Stoel, Jan Stolk, et al.
COPD|April 20, 2010
Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiencyJayne Holme, Paul A Dawkins, Ellen K Stockley, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2007
Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiencyDavid G Parr, Peter G Guest, John H Reynolds, et al.
American Journal of Respiratory and Critical Care Medicine|July 28, 2012
Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomographyDeepak R Subramanian, Lee Jenkins, Ross Edgar, et al.
Respiratory Research|October 6, 2010
Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometryRobert A Stockley, David G Parr, Eeva Piitulainen, et al.
Respiratory Research|November 23, 2006
Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive studyDavid G Parr, Andrew J White, Darren L Bayley, et al.
European Journal of Internal Medicine|April 30, 2003
Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparinAlbert Y.H. Lim, David G. Parr, David E. Stableforth, et al.
Archivos De Bronconeumologia|July 25, 2022
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research CollaborationDavid G Parr, Joanna Chorostowska-Wynimko, Angelo Corsico, et al.
Pageof 4